Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2441 – 2460 of 3236

Cost Considerations and Antiretroviral Therapy

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/antiretroviral-therapy-cost-considerations

Management of Medication Toxicity or Intolerance

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/management-medication-toxicity-or-intolerance

Hematologic Effects

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/hematologic-effects

Non-Nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs)

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/non-nucleoside-analogue-reverse-transcriptase

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/nevirapine

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/archived-drugs

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/saquinavir

Entry and Fusion Inhibitors

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/entry-and-fusion-inhibitors

Management of Children Receiving Antiretroviral Therapy

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/management-children-receiving-antiretroviral

Hepatitis B Virus Infection

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/hepatitis-b-virus-infection

Care of Infants With Perinatal Exposure to HIV

https://clinicalinfo.hiv.gov/guidelines/perinatal/management-infants-born-people-hiv-infection

Antiretroviral Management of Infants With In Utero, Intrapartum, or Breastfeeding Exposure to HIV

https://clinicalinfo.hiv.gov/guidelines/perinatal/management-infants-utero-intrapartum-breastfeeding-hiv-exposure

Fosamprenavir (Lexiva, FPV)

https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-fosamprenavir-lexiva

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/general-terms

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/introduction

Suboptimal CD4 Cell Recovery Despite Viral Suppression

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/suboptimal-cd4-cell-recovery

Hepatitis C Virus/HIV Coinfection

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/coinfections-hepatitis-c-virus-hiv

Raltegravir (Isentress, Isentress HD, RAL)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-integrase-inhibitors-raltegravir-isentress

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors

https://clinicalinfo.hiv.gov/guidelines/perinatal-hiv-clinical-guidelines/nucleoside-and-nucleotide-analogue-reverse

Drug-Drug Interactions

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-drug-interactions